BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29500881)

  • 1. NDRG4 in gastric cancer determines tumor cell proliferation and clinical outcome.
    Zhang Z; She J; Yang J; Bu X; Ji G; Zhu S; He S; Chu D
    Mol Carcinog; 2018 Jun; 57(6):762-771. PubMed ID: 29500881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
    Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S
    Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NDRG4 stratifies the prognostic value of body mass index in colorectal cancer.
    Zheng J; Li Y; Zhu S; Li J; Zhao Q; Ji G; Wang W; Chu D
    Oncotarget; 2016 Jan; 7(2):1311-22. PubMed ID: 26515606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients.
    Chu D; Zhang Z; Zhou Y; Li Y; Zhu S; Zhang J; Zhao Q; Ji G; Wang W; Zheng J
    Oncotarget; 2015 Apr; 6(10):7584-96. PubMed ID: 25749388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
    Agosta C; Laugier J; Guyon L; Denis J; Bertherat J; Libé R; Boisson B; Sturm N; Feige JJ; Chabre O; Cherradi N
    Int J Cancer; 2018 Aug; 143(4):944-957. PubMed ID: 29516499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognosis of MYOZ2 in gastric cancer.
    Li YF; Zhu GY; Ma Y; Qu HY
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5920-5927. PubMed ID: 30280773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
    Yang Z; Cheng H; Zhang Y; Zhou Y
    Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function.
    Shi HH; Liu HE; Luo XJ
    BMB Rep; 2020 Dec; 53(12):658-663. PubMed ID: 33298240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDRG2 and NDRG4 Expression Is Altered in Glioblastoma and Influences Survival in Patients with MGMT-methylated Tumors.
    Kolodziej MA; Weischer C; Reinges MH; Uhl E; Weigand MA; Schwarm FP; Schänzer A; Acker T; Quint K; Uhle F; Stein M
    Anticancer Res; 2016 Mar; 36(3):887-97. PubMed ID: 26976975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
    He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
    World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
    Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
    J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM15 Exerts Anti-Tumor Effects Through Suppressing Cancer Cell Invasion in Gastric Adenocarcinoma.
    Chen W; Lu C; Hong J
    Med Sci Monit; 2018 Nov; 24():8033-8041. PubMed ID: 30412518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
    Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
    Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
    Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
    Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTO expression is associated with the occurrence of gastric cancer and prognosis.
    Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
    Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collapsin response mediator protein 4 isoforms (CRMP4a and CRMP4b) have opposite effects on cell proliferation, migration, and invasion in gastric cancer.
    Guo H; Xia B
    BMC Cancer; 2016 Jul; 16():565. PubMed ID: 27475326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.